Dozens of Texas superintendents met with lawmakers this month in Austin to back a bill some believe could curb violence ...

The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.

If it wasn't obvious before, Latigo Biotherapeutics is all in on its non-opioid pain treatment pipeline and that is highlighted further by the company's $150 million Series B capital raise. Announced ...